Compare WLYB & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLYB | INSP |
|---|---|---|
| Founded | 1807 | 2007 |
| Country | United States | United States |
| Employees | 5200 | N/A |
| Industry | Books | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | N/A | 2018 |
| Metric | WLYB | INSP |
|---|---|---|
| Price | $38.56 | $49.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $101.07 |
| AVG Volume (30 Days) | 646.0 | ★ 1.0M |
| Earning Date | 03-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.68% | N/A |
| EPS Growth | N/A | ★ 179.43 |
| EPS | N/A | ★ 4.89 |
| Revenue | N/A | ★ $82,050,000.00 |
| Revenue This Year | $1.04 | $8.20 |
| Revenue Next Year | $2.36 | $8.44 |
| P/E Ratio | $15.27 | ★ $10.31 |
| Revenue Growth | N/A | ★ 62.18 |
| 52 Week Low | $29.16 | $50.00 |
| 52 Week High | $45.16 | $164.02 |
| Indicator | WLYB | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 69.84 | 25.39 |
| Support Level | $37.75 | N/A |
| Resistance Level | $38.63 | $84.26 |
| Average True Range (ATR) | 0.41 | 2.78 |
| MACD | 0.38 | -0.23 |
| Stochastic Oscillator | 100.00 | 6.22 |
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.